![]() |
市場調査レポート
商品コード
1619334
医薬品用ガラス包装の市場規模・シェア・成長分析 (材料別、製品別、薬剤の種類別、地域別):産業予測 (2024~2031年)Pharmaceutical Glass Packaging Market Size, Share, Growth Analysis, By Material (Type I, Type II), By Product (Vials, Bottles), By Drug Type, By Region - Industry Forecast 2024-2031 |
||||||
|
医薬品用ガラス包装の市場規模・シェア・成長分析 (材料別、製品別、薬剤の種類別、地域別):産業予測 (2024~2031年) |
出版日: 2024年12月19日
発行: SkyQuest
ページ情報: 英文 207 Pages
納期: 3~5営業日
|
世界の医薬品用ガラス包装の市場規模は、2022年に180億米ドルと評価され、2023年の199億米ドルから2031年には417億米ドルに成長し、予測期間 (2024~2031年) のCAGRは9.7%で成長する見通しです。
医薬品用ガラス包装市場は、医薬品分野の拡大と、非反応性でリサイクル可能なガラスに対する消費者の嗜好によって力強い成長を遂げています。特に欧州や西半球の先進地域では、持続可能な社会の実現に向け、ガラスリサイクルへの取り組みが加速しています。大手物流企業が競争力強化のために革新的なソリューションに投資しており、技術の進歩が市場を形成しつつあります。一方、製薬会社が廃棄物や二酸化炭素排出量を最小限に抑えようと努力する中、環境に優しい包装へのシフトが加速しています。ガラス瓶は完全にリサイクル可能で、最も環境に優しい選択肢として際立っています。印刷とラベリング技術の進歩に後押しされたカスタマイズとパーソナライゼーションの台頭は、この市場の進化するダイナミクスをさらに際立たせています。
Global Pharmaceutical Glass Packaging Market size was valued at USD 18 billion in 2022 and is poised to grow from USD 19.9 billion in 2023 to USD 41.7 billion by 2031, growing at a CAGR of 9.7% during the forecast period (2024-2031).
The pharmaceutical glass packaging market is experiencing robust growth driven by the expanding pharmaceutical sector and a consumer preference for glass due to its non-reactivity and recyclability. Glass recycling initiatives are escalating, especially in developed regions of Europe and the western hemisphere, spurred by a collective push for sustainable practices. Technological advancements are reshaping the market as major logistics companies invest in innovative solutions to enhance competitiveness. Meanwhile, the industry's shift towards eco-friendly packaging is accelerating as pharmaceutical companies strive to minimize waste and their carbon footprint. Glass jars stand out as the most environmentally friendly option, being completely recyclable. The rise in customization and personalization, fueled by advancements in printing and labeling technologies, further underscores the evolving dynamics in this market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Glass Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Glass Packaging Market Segmental Analysis
Global Pharmaceutical Glass Packaging Market is segmented by Material, Product, Drug Type and Region. Based on Material, the market is segmented into Type I, Type II, Type, III. Based on Product, the market is segmented into Vials, Bottles, Cartridges and Syringes, Ampoules. Based on Drug Type, the market is segmented into Generic, Branded, Biologic. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pharmaceutical Glass Packaging Market
The increasing utilization of biologics, such as monoclonal antibodies and vaccines, is a significant catalyst for the growth of the global pharmaceutical glass packaging market. As the need for biologics rises, the demand for secure, sterile, and high-quality packaging intensifies, emphasizing the importance of glass vials and syringes in the healthcare industry. The effectiveness of these biologics relies on the integrity of their packaging, thus driving the market for pharmaceutical glass packaging further. This trend highlights the crucial role that glass packaging plays in the safe and efficient delivery of biologic therapies, ultimately boosting market expansion and development opportunities.
Restraints in the Global Pharmaceutical Glass Packaging Market
One of the significant challenges facing the global pharmaceutical glass packaging market is the increasing preference for alternative packaging materials, such as plastic and metal. These alternatives are often more affordable, lighter, and offer greater flexibility, making them appealing options for pharmaceutical companies seeking cost-effective solutions. As these materials continue to gain traction due to their practical advantages, they pose a notable restraint to the glass packaging sector. This shift in preference could potentially hinder the growth of the glass packaging market, as manufacturers and suppliers are compelled to adapt to changing demands and explore innovative packaging solutions.
Market Trends of the Global Pharmaceutical Glass Packaging Market
The Global Pharmaceutical Glass Packaging market is witnessing a significant trend driven by the surging demand for biologic drug packaging. As biologics, such as vaccines and monoclonal antibodies, gain prominence in therapeutics, the necessity for specialized glass packaging solutions is intensifying. Glass vials and syringes are becoming indispensable for ensuring a sterile and stable environment crucial for preserving the efficacy of these sensitive drugs. This shift towards advanced packaging solutions is fostering innovation in material design and manufacturing processes, thereby propelling market growth, catering to the stringent requirements of the pharmaceutical industry and enhancing patient safety.